Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:16 PM
Ignite Modification Date:
2026-03-26 @ 3:16 PM
NCT ID:
NCT07329257
Eligibility Criteria:
For those with a rare condition:
Inclusion Criteria:
* Diagnosed or suspected neurogenetic disorder
* Individuals 0-99
Exclusion Criteria:
* Individuals unwilling or unable to complete visits with the study team.
For control parents/caregivers of those with a rare condition:
Inclusion Criteria:
* No history of a neurological disorder.
* \>18 years.
* Legal caregiver of the patient diagnosed with a rare neurodevelopmental disorder.
Exclusion Criteria:
* Individuals unwilling or unable to complete the visit with the study team.
* Individuals who have a history of neurological disorders.
* \< 18 years old
For all individuals who participate in the skin biopsy:
* Individuals with disease that is known to be associated with poor wound healing.
* Individuals with a history of allergic reaction to lidocaine.
* Medical History of cellulitis, diabetes mellitus, poor extremity circulation, deep vein thrombosis, or a history of non-traumatic amputation.
* Currently taking anticoagulation or have taken with last 6 months
Healthy Volunteers:
True
Sex:
ALL
Maximum Age:
99 Years
Study:
NCT07329257
Study Brief:
Protocol Section:
NCT07329257